AstraZeneca License With Regeneron For VelocImmune Could Spark Industry Trend
Regeneron is seeking to sign multiple deals offering access to the next-generation human monoclonal antibody discovery technology, exec tells "The Pink Sheet" DAILY.
Regeneron is seeking to sign multiple deals offering access to the next-generation human monoclonal antibody discovery technology, exec tells "The Pink Sheet" DAILY.